STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Adaptive Biotechnologies Corp

Filed

March 6, 2024

Period of Report

March 4, 2024

Accession Number

0001062993-24-005772